This inventor holds 4 USPTO granted patents and 7 published patent applications. Top assignee: Kudos Pharmaceuticals Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Benedikt Steitz: Innovator in Pharmaceutical Formulations
Introduction
Benedikt Steitz is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 4 patents to his name, Steitz continues to push the boundaries of pharmaceutical science.
Latest Patents
One of his latest patents involves an immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one. This invention relates to a pharmaceutical formulation that comprises the drug in a solid dispersion with a matrix polymer exhibiting low hygroscopicity and high softening temperature, such as copovidone. The formulation aims to enhance the bioavailability of the drug, providing a daily pharmaceutical dose that is both effective and efficient.
Career Highlights
Benedikt Steitz has established himself as a key figure in the pharmaceutical industry. He is currently associated with Kudos Pharmaceuticals Limited, where he applies his expertise in drug formulation and development. His work has been instrumental in advancing pharmaceutical technologies that improve patient outcomes.
Collaborations
Steitz has collaborated with several professionals in the field, including Michael Karl Bechtold and Julie Kay Cahill. These collaborations have fostered innovation and have contributed to the successful development of new pharmaceutical products.
Conclusion
Benedikt Steitz is a prominent inventor whose work in pharmaceutical formulations has made a significant impact on the industry. His innovative approaches continue to enhance drug delivery systems, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile